AC Immune (ACIU) EBT Growth (3y) (2018 - 2026)
AC Immune (ACIU) EBT Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
28.95% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-49.71% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
20.92% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
12.01% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
AC Immune |
1.45 Bn |
-94.07 Bn |
- |
0.05% |
| Date | Value |
|---|
| Mar 31, 2026 |
0.05% |
| Dec 31, 2025 |
2.60% |
| Sep 30, 2025 |
-12.32% |
| Jun 30, 2025 |
-7.87% |
| Mar 31, 2025 |
-1.23% |
| Dec 31, 2024 |
7.89% |
| Sep 30, 2024 |
33.26% |
| Jun 30, 2024 |
-6.37% |
| Mar 31, 2024 |
-3.40% |
| Dec 31, 2023 |
37.18% |
| Sep 30, 2023 |
6.00% |
| Jun 30, 2023 |
-4.65% |
| Mar 31, 2023 |
-33.54% |
| Dec 31, 2022 |
0.32% |
| Sep 30, 2022 |
-40.22% |
| Jun 30, 2022 |
-6.56% |
| Mar 31, 2022 |
-32.38% |
| Dec 31, 2021 |
-16.08% |
| Sep 30, 2021 |
-8.07% |
| Jun 30, 2021 |
-22.70% |
